CHOP researchers found that a series of “liquid biopsies” could less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.

Researchers from Children’s Hospital of Philadelphia (CHOP) found disparities in the completion of follow-up concussion care which will help inform future research at CHOP funded by a CDC grant that specifically aims to address such disparities.

CHOP researchers have found nearly one-third of very premature infants develop late-onset sepsis and that 1 in 2 infants born at 23 weeks or earlier either died and/or developed the infection.

Researchers from Children’s Hospital of Philadelphia (CHOP) have found that economically disadvantaged children treated with CAR T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (ALL) fair just as well as children from more socioeconomically advantaged backgrounds.

Study also suggests vaccine timing is important in maximizing concentration of antibodies transferred to the baby.

CHOP researchers have identified a protein on the surface of multiple pediatric brain tumors that they can target using immunotherapy in preclinical models.

The model helped identify two supplements that appeared to have therapeutic benefits.

The award is given to a medical school faculty member who has “made major contributions to improving public health and health care.”

Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, has signed a Memorandum of Understanding (MoU) with Children’s Hospital of Philadelphia (CHOP) to facilitate enhanced international collaboration and further propel the quality of medical education, research, and patient experience within the UAE.

In a retrospective study, researchers from the Mitochondrial Medicine Frontier Program at Children’s Hospital of Philadelphia (CHOP) and Lund University in Sweden determined the prevalence, severity, and timing of onset for hearing loss across different genetic subtypes of mitochondrial disease.